Best-Selling Animal Anthelmintic Drug - Sulfadoxine+pyrimethamine tablets – KeMing Medicines Detail:
FOB Price | Inquiry |
Min.Order Quantity | 1,000,000 tablets |
Supply Ability | 120,000,000 tablets/Month |
Port | Shanghai |
Payment Terms | T/T in advance |
Product Detail | |
Product name | Sulfadoxine+pyrimethamine tablets |
Specification | 500mg+25mg |
Description | A white tablets |
Standard | USP |
Package | 3tablets/box |
Transportation | Ocean,Land,Air |
Certificate | GMP |
Price | Inquiry |
Quality guaranteeperiod | for 36 months |
Product Description | [Indications]:Treatment of plasmodium falciparum malaria especially in
patients and in areas where P falciparum malaria resistant to chloroquine is suspected. 9-14 years:2 tabs,4-8 years:1 tab,<4 years:1/2tab Ail doses are to be taken once daily.Malaria Prophylaxis:The first dose of FANS-MINE should be taken 1 or 2 weeks before departure to n endemic area,administration should be continued during the stay and for 4-6 weeks after return. |
Product detail pictures:
Related Product Guide:
Prescription Drugs Can Lead to Vitamin and Mineral Deficiencies
Cholesterol Drugs and Low Vitamin D Along With Other Hormone Levels
Well-run products, skilled income group, and better after-sales products and services; We have been also a unified massive family, all people stick with the business price "unification, dedication, tolerance" for Best-Selling Animal Anthelmintic Drug - Sulfadoxine+pyrimethamine tablets – KeMing Medicines, The product will supply to all over the world, such as: Moldova, Mauritius, Rome, With the goal of "zero defect". To care for the environment, and social returns, care employee social responsibility as own duty. We welcome friends from all over the world to visit and guide us so that we can achieve the win-win goal together.
By Antonio from Vietnam - 2018.12.22 12:52
This company conforms to the market requirement and joins in the market competition by its high quality product, this is an enterprise that have Chinese spirit.
By Anna from Madras - 2018.11.28 16:25